Ban on Krka's Sales of Donepezil in Norway Lifted

Ljubljana, 13 March - The Swedish subsidiary of the Slovenian generics maker Krka will start marketing Donepezil in Norway after the High Court in Oslo has annulled a temporary ban due to patent violation, according to Friday's press release from Krka.

The rest of this news item is available to subscribers.
The news item consists of 459 characters (without spaces) or 87 words words.

Buy the news item. Price: 2 tokens; on account: 0 tokens.

© STA, 2009